Trichomislin, a novel ribosome-inactivating protein, induces apoptosis that involves mitochondria and caspase-3

Shuang-Li Mi1, Cheng-Cai An, Ye Wang

  • 1The National Laboratory of Protein Engineering and Plant Genetic Engineering, College of Life Sciences, Peking University, Beijing 100871, China.

Insights

A novel protein, trichomislin, from Trichosanthes kirilowii, inhibits protein synthesis and induces apoptosis in choriocarcinoma cells by activating caspases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Ribosome-inactivating proteins (RIPs) are a class of proteins with cytotoxic properties.
  • Trichosanthes kirilowii Maxim. is a plant known for its medicinal properties.

Purpose of the Study:

  • To clone, express, and characterize a novel RIP, trichomislin, from Trichosanthes kirilowii.
  • To investigate the mechanism of action and antitumor effects of trichomislin.

Main Methods:

  • Gene cloning and prokaryotic expression of trichomislin.
  • Protein purification using cation-exchange chromatography.
  • Circular-dichroism analysis for secondary structure determination.
  • In vitro protein synthesis inhibition assays.
  • Antitumor activity assessment in choriocarcinoma cell lines.
  • Caspase-3 activity and cytochrome c release assays.

Main Results:

  • Trichomislin was successfully cloned, expressed, and purified.
  • Circular-dichroism analysis revealed the secondary structure composition.
  • Trichomislin inhibited protein synthesis by inactivating ribosomes as an rRNA N-glycosidase.
  • Trichomislin induced apoptosis and inhibited choriocarcinoma cell growth.
  • Trichomislin triggered apoptosis via the mitochondrial pathway, involving caspase-3 activation and cytochrome c release.

Conclusions:

  • Trichomislin is a novel ribosome-inactivating protein with potent antitumor activity.
  • The antitumor mechanism involves inducing apoptosis through the mitochondrial pathway.
  • Trichomislin holds potential as a therapeutic agent for choriocarcinoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...